• Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University, Shanghai, 200040, P.R.China;
CHEN Zhiming, Email: chzm_md@163.com
Export PDF Favorites Scan Get Citation

Objective  To investigate the clinical outcomes of subxiphoid video-assisted thoracoscopic thymectomy for myasthenia gravis. Methods  The clinical data of the 85 patients undergoing video-assisted thoracoscopic thymectomy for myasthenia gravis in Department of Cardiothoracic Surgery, Huashan Hospital affiliated to Fudan University between January 2014 and July 2016 were studied. Subxiphoid approach video-assisted thoracoscopic thymectomy (SXVT) and through traditional unilateral approach video-assisted thymectomy (TVAT) were compared. The clinical outcomes of SXVT and TVAT were compared. Results  There was no surgical death and no statistical difference between the two groups in drainage time, postoperative volume of drainage, postoperative hospital stay and bleeding volume during operation (P>0.05). However, the acute chest pain after surgery, as well as the postoperative chest pain, and operative time were less in the the SXVT group than that in the TVAT group (P<0.05). Conclusion  SXVT for myasthenia gravis is safe and executable. It can alleviate intercostal neuralgia and abnormal chest wall feeling. And it should be considered in the treatment of myasthenia gravis.

Citation: XU Pengliang, CHEN Gang, ZHU Yongjun, SONG Yang, PANG Liewen, CHEN Zhiming. Subxiphoid video-assisted thoracoscopic thymectomy versus traditional video-assisted thoracic surgery thymectomy for myasthenia gravis: A case control study. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(9): 799-803. doi: 10.7507/1007-4848.201710010 Copy

  • Previous Article

    Application of methylene blue staining for precise positioning of small esophageal leiomyoma during video-assisted thoracoscopic surgery via one utility port
  • Next Article

    A preliminary discussion on establishment of patient-derived tumor xenograft (PDTX) model and testing of pharmacodynamics